Search Results

You searched for : PharmaNewsUpdate  

Asymchem Acquires Snapdragon Chemistry

Latest Corporate News update ; Pharma...
Feb 14

Health Decisions and OncoBay Clinical partners for development services in women's oncology

...
Dec 03

APEIRON Biologics AG and Domainex Ltd partnership to progress targeted cancer immune therapy drug discovery

Integrated lead optimisation to advance APEIRON’s Cbl-b inhibitor development programme APN431...
Nov 11

Impel Neuropharma reports FDA submission of new drug application For INP104

INP104 is indicated in treatment of acute migraine...
Nov 10

EIP Pharma Announces Presentation of Positive Clinical Trial Results with Neflamapimod

Results were presented at the 13th Clinical Trials in Alzheimer's Disease (CTAD) Meeting...
Nov 09

Synthace and Ipsen partner to accelerate novel therapeutic development through automation

Biopharmaceutical companies like Ipsen are partnering with specialists in integrating the digital and physical aspects of R&D...
Nov 07

Lonza announces agreement to manufacture AstraZeneca’s COVID-19 long-acting antibody combination

Lonza and AstraZeneca collaborates to handle Covid challenge...
Nov 04

Novartis expands Kymriah manufacturing footprint in Asia

first-ever approved site for commercial CAR-T cell therapy manufacturing in Asia...
Oct 31

CStone and LegoChem Biosciences enter into global licensing agreement

CStone is a biopharmaceutical company focused on the development and commercialization of innovative immuno-oncology and precision drugs ...
Oct 30

Passage Bio’s PBGM01 receives Orphan Drug Designation from EMA for treatment of GM1 Gangliosidosis

...
Oct 27

NBE-Therapeutics starts first clinical Study of Anti-ROR1 Antibody-Drug conjugate for patients with solid tumors

Anti-tumor immune memory and iADC platform are showing results ...
Oct 27

Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus

Sai Life expands organizational transformation areas...
Oct 27

Helix Technologies, Inc. and Medical Outcomes Research Analytics, LLC to Combine

Forian Inc. to Become Industry Leading Information, Analytics and Technology Provider for Healthcare and Cannabis Industries ...
Oct 19

Regeneron’s Antibody cocktail REGN-EB3 (Inmazeb) is first FDA-Approved treatment for Ebola

First FDA approved antibody treatment for Ebola...
Oct 19

Aimmune Receives Positive CHMP opinion on PALFORZIA ; treatment of patients with peanut allergy

PALFORZIA recieves CHMP for Europe...
Oct 19

Lancet debunks Lopinavir- Ritonavir as effective treatment for patients hospitalized with COVID-19

Antiviral drugs are under lens for their effectiveness...
Oct 06

Bristol Myers Squibbs get FDA approval for Opdivo and Yervoy : Malignant Pleural Mesothelioma

Opdivo + Yervoy is the first new systemic therapy in over 15 years to be approved by the FDA ...
Oct 03

HUYA Bioscience announces orphan drug Designation for HBI-8000 in Japan

HBI-8000 for Monotherapy Adult T-cell Leukemia-Lymphoma ATL ...
Oct 01

Ajinomoto Bio-Pharma Services and DNDi Partner to develop Critical Immunomodulator

Partners will develop Critical Immunomodulator for Cutaneous Leishmaniasis Therapeutic...
Sep 30

China's Kangtai gets approval for clinical trial of coronavirus vaccine candidate

China's Kangtai Biological Products cleared for human trial while Chinese Academy of Medical Sciences vaccine candidate is in mid-stage trial....
Sep 29

FDA grants IND Approval for Stemedica's itMSC Therapy for COVID-19 Patients

The study will enrol up to 40 patients into two cohorts, randomized 1:1 to receive the active study drug plus standard treatment or placebo...
Sep 29

Lupin Launches Fosaprepitant for injection ; emetogenic cancer chemotherapy

150 mg Single-Dose Vial, having received an approval from the United States Food and Drug Administration (U.S. FDA) earlier....
Sep 28

Zymo Research granted CE IVD Mark for sample collection devices

Zymo Research was granted the CE IVD mark for its DNA/RNA Shield reagent and collection devices. ...
Sep 28

Hetero's new Favivir packaging for Covid-19 with 800 mg dosage cuts pill burden

The higher strength of Favipiravir 800 mg from Hetero has been approved by the Drug Controller General of India ...
Sep 26

Millendo Therapeutics reports First-in-Human Clinical Trial of MLE-301 for VSM

VMS, is commonly known as hot flashes and night sweats, in menopausal women....
Sep 26

25 Matching result(s) found!

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026